drugset / Trial / NCT00002424
A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and Lamivudine
Double-blindTreatment
Summary
This study will see how safe and effective against HIV the drugs L-756423 plus indinavir (IDV) are compared to just IDV when taken with stavudine (d4T) and lamivudine (3TC). The study will also see whether taking 1 large dose of L-756423/IDV once a day is as safe and effective as taking 2 smaller doses twice a day.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | INDINAVIR ANHYDROUS | Other / unclassified | 400 mg | — |
| Subject | INDINAVIR ANHYDROUS | Other / unclassified | 800 mg | — |
| Subject | L-756423 | Small molecule | 800 mg | — |
| Subject | L-756423 | Small molecule | 1600 mg | — |
| Background | Lamivudine | Other / unclassified | — | — |
| Background | Stavudine | Other / unclassified | — | — |